In:
Journal of Neurochemistry, Wiley, Vol. 105, No. 2 ( 2008-04), p. 401-412
Abstract:
In cultured bovine adrenal chromaffin cells, chronic (≥ 24 h) treatment with lysophosphatidic acid (LPA) augmented veratridine‐induced 22 Na + influx via Na v 1.7 by ∼22% (EC 50 = 1 nmol/L), without changing nicotine‐induced 22 Na + influx via nicotinic receptor‐associated channel. LPA enhanced veratridine (but not nicotine)‐induced 45 Ca 2+ influx via voltage‐dependent calcium channel and catecholamine secretion. LPA shifted concentration–response curve of veratridine for 22 Na + influx upward, without altering the EC 50 of veratridine. Ptychodiscus brevis toxin‐3 allosterically enhanced veratridine‐induced 22 Na + influx by twofold in non‐treated and LPA‐treated cells. Whole‐cell patch‐clamp analysis showed that peak Na + current amplitude was greater by 39% in LPA (100 nmol/L for 36 h)‐treated cells; however, I–V curve and steady‐state inactivation/activation curves were comparable between non‐treated and LPA‐treated cells. LPA treatment (≥ 24 h) increased cell surface [ 3 H]saxitoxin binding by ∼28%, without altering the K d value; the increase was prevented by cycloheximide, actinomycin D, or Ki16425, dioctylglycerol pyrophosphate 8:0 (two inhibitors of LPA 1 and LPA 3 receptors), or botulinum toxin C3 (Rho inhibitor), Y27632 (Rho kinase inhibitor), consistent with LPA 1 receptor expression in adrenal chromaffin cells. LPA raised Na v 1.7 mRNA level by ∼37%. Thus, LPA–LPA 1 receptor–Rho/Rho kinase pathway up‐regulated cell surface Na v 1.7 and Na v 1.7 mRNA levels, enhancing veratridine‐induced Ca 2+ influx and catecholamine secretion.
Type of Medium:
Online Resource
ISSN:
0022-3042
,
1471-4159
DOI:
10.1111/jnc.2008.105.issue-2
DOI:
10.1111/j.1471-4159.2007.05143.x
Language:
English
Publisher:
Wiley
Publication Date:
2008
detail.hit.zdb_id:
2020528-4
SSG:
12
Permalink